LAG-3: a very singular immune checkpoint
The mechanism of action of the lymphocyte checkpoint protein LAG-3 was always rather mysterious. It now seems to operate at least in part by recognizing and suppressing responses to stable complexes of peptide and major histocompatibility complex class II.
Κύριοι συγγραφείς: | Lui, Y, Davis, S |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
Springer Nature
2018
|
Παρόμοια τεκμήρια
-
The promising immune checkpoint LAG-3 in cancer immunotherapy: from basic research to clinical application
ανά: Huo, Jin-Ling, κ.ά.
Έκδοση: (2022) -
Immune checkpoints as therapeutic targets in autoimmunity
ανά: Paluch, C, κ.ά.
Έκδοση: (2018) -
CHECKPOINT ATHERO: developing immune checkpoint-based therapeutics for atherosclerosis
ανά: Lutgens, E, κ.ά.
Έκδοση: (2023) -
Singular vector autoregressions with deterministic terms: Strong consistency and lag order determination.
ανά: Nielsen, B
Έκδοση: (2008) -
Characterising peripheral responses to immune checkpoint inhibitors
ανά: Cooper, R
Έκδοση: (2021)